Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models

被引:51
作者
Noumbissi, Midrelle E. [1 ]
Galasso, Bianca [1 ]
Stins, Monique F. [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, 615 N Wolfe St,SPH East 4135, Baltimore, MD 21205 USA
关键词
Blood-brain barrier; Cerebral vasculature; Grey matter; In vitro models; Neurodegeneration; Neurovascular unit; White matter; INTERCELLULAR-ADHESION MOLECULE-1; CAPILLARY ENDOTHELIAL-CELLS; TIGHT JUNCTION PROTEINS; AMINO-ACID-TRANSPORT; FLUID SHEAR-STRESS; WHITE-MATTER; CEREBRAL MALARIA; COL4A1; MUTATIONS; EXTRACELLULAR-MATRIX; NEUROVASCULAR UNIT;
D O I
10.1186/s12987-018-0097-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The vertebrate blood-brain barrier (BBB) is composed of cerebral microvascular endothelial cells (CEC). The BBB acts as a semi-permeable cellular interface that tightly regulates bidirectional molecular transport between blood and the brain parenchyma in order to maintain cerebral homeostasis. The CEC phenotype is regulated by a variety of factors, including cells in its immediate environment and within functional neurovascular units. The cellular composition of the brain parenchyma surrounding the CEC varies between different brain regions; this difference is clearly visible in grey versus white matter. In this review, we discuss evidence for the existence of brain vascular heterogeneity, focusing on differences between the vessels of the grey and white matter. The region-specific differences in the vasculature of the brain are reflective of specific functions of those particular brain areas. This BBB-endothelial heterogeneity may have implications for the course of pathogenesis of cerebrovascular diseases and neurological disorders involving vascular activation and dysfunction. This heterogeneity should be taken into account when developing BBB-neuro-disease models representative of specific brain areas.
引用
收藏
页数:12
相关论文
共 206 条
[1]   Blood-brain barrier structure and function and the challenges for CNS drug delivery [J].
Abbott, N. Joan .
JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) :437-449
[2]   Overview and introduction: The blood-brain barrier in health and disease [J].
Abbott, N. Joan ;
Friedman, Alon .
EPILEPSIA, 2012, 53 :1-6
[3]  
Abbott NJ, 2012, METHODS MOL BIOL, V814, P415, DOI 10.1007/978-1-61779-452-0_28
[4]   Structure and function of the blood-brain barrier [J].
Abbott, N. Joan ;
Patabendige, Adjanie A. K. ;
Dolman, Diana E. M. ;
Yusof, Siti R. ;
Begley, David J. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :13-25
[5]   Astrocyte-endothelial interactions at the blood-brain barrier [J].
Abbott, NJ ;
Rönnbäck, L ;
Hansson, E .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53
[6]   'Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome [J].
Alamowitch, S. ;
Plaisier, E. ;
Favrole, P. ;
Prost, C. ;
Chen, Z. ;
Van Agtmael, T. ;
Marro, B. ;
Ronco, P. .
NEUROLOGY, 2009, 73 (22) :1873-1882
[7]   Is the pial microvessel a good model for blood-brain barrier studies? [J].
Allt, G ;
Lawrenson, JG .
BRAIN RESEARCH REVIEWS, 1997, 24 (01) :67-76
[8]   Extracellular vesicles of the blood-brain barrier [J].
Andras, Ibolya E. ;
Toborek, Michal .
TISSUE BARRIERS, 2016, 4 (01)
[9]   An Oligovascular Niche: Cerebral Endothelial Cells Promote the Survival and Proliferation of Oligodendrocyte Precursor Cells [J].
Arai, Ken ;
Lo, Eng H. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (14) :4351-4355
[10]   Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease [J].
Argaw, Azeb Tadesse ;
Asp, Linnea ;
Zhang, Jingya ;
Navrazhina, Kristina ;
Trinh Pham ;
Mariani, John N. ;
Mahase, Sean ;
Dutta, Dipankar J. ;
Seto, Jeremy ;
Kramer, Elisabeth G. ;
Ferrara, Napoleone ;
Sofroniew, Michael V. ;
John, Gareth R. .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (07) :2454-2468